SCHEMBL14933544

SCHEMBL14933544

CC1(C)c2ccccc2-c2cc3c4ccccc4c(=O)n(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c3cc21

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.36
BRD4 O60885 4/20 0.35
PGR P06401 5/20 0.35
KMT2A Q03164 1/20 0.34
PDE10A Q9Y233 1/20 0.33
BRD9 Q9H8M2 1/20 0.33
BRD7 Q9NPI1 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
GSK3B P49841 1/20 0.31
HSD17B10 Q99714 1/20 0.31
BRDT Q58F21 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14933583 0.94 BRD4 (0.33) MAPK1BRD4PGRKMT2APDE10A
SCHEMBL14933565 0.92 KMT2A (0.34) MAPK1BRD4PGRKMT2APDE10A
SCHEMBL12292010 0.89 PGR (0.35) PGR
SCHEMBL14933547 0.88 KMT2A (0.38) BRD4PGRKMT2APDE10AL3MBTL1
SCHEMBL782283 0.87 KDM4E (0.37) PGRL3MBTL1GSK3BHSD17B10
SCHEMBL14933306 0.87 KMT2A (0.36) MAPK1BRD4PGRKMT2APDE10A
SCHEMBL14849702 0.87 PGR (0.33) MAPK1PGRHSD17B10
SCHEMBL18518703 0.86 KDM4E (0.36) PGRL3MBTL1GSK3B
SCHEMBL14933411 0.86 MAPT (0.37) MAPK1BRD4PGRNPSR1L3MBTL1
SCHEMBL14933582 0.85 MAPT (0.36) MAPK1PGRKMT2ABRD9BRD7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649213-B1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-06-23 EP disclosed
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
WO-2019007867-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-01-10 WO disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 MAPK1 4607/4885BRD4 2427/4885PGR 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.